hIL3/hCSF2
Nomenclature
C57BL/6JSmo-Il3tm3(hIL3)Csf2tm3(hCSF2)/Smoc
Cat. NO.
NM-HU-190065
Strain State
Embryo cryopreservation
Model Description
Validation Data
Fig.1 Detection of mCSF2(A) and hCSF2(B) expression in serum by ELISA(n=3).
Abbr. HO, homozygous; WT, wild type; N.D. not detected
Note.hIL3/hCSF2 and C57BL/6 mice were i.p. injected with LPS for 2h.
Fig.2 Detection of mIL3(A) and hIL3(B) expression in splenocyte by ELISA(n=3).
Abbr. HO, homozygous; WT, wild type; N.D. not detected.
Note. Splenocyte were stimulated with ConA and IL2 in vitro for 48h.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
